Truqap is often a kinase inhibitor that actually works by blocking pathways that help the most cancers cells endure and mature, so decreases cancer development. Truqap is from a class of medicines known as an AKT inhibitor. Truqap gained FDA approval on November 17, 2023, following optimistic results in the https://charlesz111kvf3.bloginder.com/profile